"Androstenedione" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A delta-4 C19 steroid that is produced not only in the TESTIS, but also in the OVARY and the ADRENAL CORTEX. Depending on the tissue type, androstenedione can serve as a precursor to TESTOSTERONE as well as ESTRONE and ESTRADIOL.
| Descriptor ID |
D000735
|
| MeSH Number(s) |
D04.210.500.054.079.329 D04.210.500.578.502.112 D06.472.040.502.112 D06.472.334.851.968.875
|
| Concept/Terms |
Androstenedione- Androstenedione
- delta-4-Androstenedione
- delta 4 Androstenedione
- 4-Androstene-3,17-dione
- 4 Androstene 3,17 dione
|
Below are MeSH descriptors whose meaning is more general than "Androstenedione".
Below are MeSH descriptors whose meaning is more specific than "Androstenedione".
This graph shows the total number of publications written about "Androstenedione" by people in this website by year, and whether "Androstenedione" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2004 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Androstenedione" by people in Profiles.
-
Steroid profiling by tandem mass spectrometry improves the positive predictive value of newborn screening for congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2004 Aug; 89(8):3687-93.
-
Improved specificity of newborn screening for congenital adrenal hyperplasia by second-tier steroid profiling using tandem mass spectrometry. Clin Chem. 2004 Mar; 50(3):621-5.
-
Evidence for different aetiologies of low estradiol response to FSH: age-related accelerated luteinization of follicles or presence of ovarian autoantibodies. Hum Reprod. 2002 Oct; 17(10):2641-9.
-
Cryptic 21-hydroxylase deficiency in families of patients with classical congenital adrenal hyperplasia. J Clin Endocrinol Metab. 1980 Dec; 51(6):1316-24.